Search results
Jeffrey SWAB, Leader, Modeling & Characterization Team, Ceramics & Transparent Materials Branch | Cited by 1,521 | | Read 158 publications | Contact Jeffrey SWAB
- On This Page
- Screening
- Diagnostic Testing
C. trachomatis
Screening for C. trachomatisis recommended for anyone with risk factors for infection. Screening is effective for detecting and treating asymptomatic infections as well as preventing complications, transmission and reinfection. Although females experience the majority of chlamydia infectionsFootnote 1, asymptomatic males under 25 can be a reservoir for infection and reinfection of their sexual partners.Footnote 2 Additional data are needed to determine whether routine screening of asymptomati...
LGV
Routine LGV genotyping of asymptomatic chlamydia infections is not recommended. Consider LGV genotyping when an asymptomatic rectal chlamydia infection is diagnosed in gay, bisexual and other men who have sex with men (gbMSM) with risk factors for LGV.
Other Sexually transmitted and blood-borne infections
STBBI screening varies by age, gender/sex, medical and sexual history. Screen anyone who presents with STBBI risk factors and treat as appropriate to prevent transmission and reinfection. People with Neisseria gonorrhoeae often have a co-infection with C. trachomatis. Infection with C. trachomatis can increase the risk of acquisition and transmission of human immunodeficiency virus (HIV).Footnote 20Footnote 21Footnote 22 People being evaluated or treated for a chlamydia infection should be sc...
C. trachomatis
Clinical presentation and sexual history determine which specimens should be collected and the type of test to use.Footnote 18Footnote 19 Nucleic Acid Amplification Tests (NAATs) are the most sensitive test for C. trachomatis. Culture for C. trachomatisFootnote 24Footnote 25is no longer routinely available in Canada. Results are highly dependent on the type of test, specimen collection / transport and laboratory expertise. Consult with local laboratory regarding available tests, specimen coll...
LGV
LGV diagnosis is not straightforward. It is often based on history and clinical presentation, supported by laboratory testing. Clinicians should have a high index of suspicion for LGV in people who present with consistent signs/symptoms (e.g. proctitis and/or marked inguinal or femoral lymphadenopathy or buboes) and/or if their history suggests exposure. Identification of C. trachomatisin bubo fluid is highly suggestive of LGV, even prior to or without identification of LGV genotypes. Buboes...
Nucleic acid amplification testing (NAAT) is the recommended method for initial screening or testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections.
MyVisit Pre-departure testing offers: COVID-19 PCR/NAAT swab testing; COVID-19 Antibody Blood (serology) testing; The MyVisit fee is $80 per person.
Feb 11, 2022 · The contents of a COVID-19 antigen rapid test kit. Ontario's science advisers are now recommending swabbing both the mouth and nose while using the tests. (Jeff McIntosh/The Canadian Press)
Diagnostic testing. Consider a diagnosis of syphilis in anyone with signs or symptoms compatible with syphilis. Depending on the stage and clinical presentation, diagnostic testing may be done on blood, lesions and/or samples of cerebrospinal fluid.
People also ask
Can a swab test help prevent cervical cancer in Canada?
Can a vaginal swab be used to screen for C trachomatis?
Which swabs are validated for PCR?
Where should a swab be taken?
Nov 22, 2023 · Canada is now moving away from using Pap smears to screen for cervical cancer screening in favour of HPV, which is more effective and can be done at home.
